RFS (univariate analysis) | RFS (multivariate analysis) | |||
---|---|---|---|---|
Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | |
Age (>63.5 years) | 1.84 (0.74-4.63) | 0.19 | ||
Sex | ||||
Female | 1 (reference) | |||
Male | 0.77 (0.24-2.38) | 0.651 | ||
Operative method | ||||
Open | 1 (reference) | 1 (reference) | ||
Laparoscopy | 1.95 (0.78-4.87) | 0.152 | 4.68 (1.61-13.61) | 0.005 |
Intent to treat | ||||
Palliative | 1 (reference) | |||
Cure | 0.58 (0.23-1.49) | 0.265 | ||
Synchronous metastasis | 1.95 (0.72-5.26) | 0.186 | ||
Site of metastasis | ||||
Single | 1 (reference) | |||
Both | 0.74 (0.15-3.56) | 0.714 | ||
Adrenal + other site | 1.02 (0.39-2.60) | 0.967 | ||
Site of primary tumor | ||||
Other | 1 (reference) | |||
Liver | 0.51 (0.11-2.24) | 0.373 | ||
Stomach | 0.15 (0.01-1.45) | 0.103 | ||
Kidney | 0.63 (0.11-3.58) | 0.604 | ||
Lung | 1.68 (0.57-4.94) | 0.346 | ||
Previous metastasectomy | ||||
No | 1 (reference) | |||
Yes | 0.33 (0.04-2.55) | 0.294 | ||
C-reactive protein (mg/dl) | ||||
≤1.0 | 1 (reference) | |||
>1 | 7.55 (1.69-33.6) | 0.008 | ||
Albumin (g/dl) | ||||
≥3.5 | 1 (reference) | |||
<3.5 | 2.03 (0.83-4.93) | 0.118 | ||
GPS | ||||
0 | 1 (reference) | 1 (reference) | ||
1 | 2.82 (0.73-10.9) | 0.132 | 2.77 (0.61-12.69) | 0.189 |
2 | 6.47 (1.64-25.3) | 0.007 | 11.80 (2.50-55.70) | 0.002 |
ECOG-PS | ||||
0-1 | 1 (reference) | |||
2 | 2.03 (0.65-6.32) | 0.222 |